A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5-Reference-Cited by-同舟云学术

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5

Published:2008-06-16 Issue:18 Volume:17 Page:2868-2876
ISSN:0964-6906
Container-title:Human Molecular Genetics
language:en
Short-container-title:Human Molecular Genetics

Author:

Sigurdsson S.,Nordmark G.,Garnier S.,Grundberg E.,Kwan T.,Nilsson O.,Eloranta M.-L.,Gunnarsson I.,Svenungsson E.,Sturfelt G.,Bengtsson A. A.,Jonsen A.,Truedsson L.,Rantapaa-Dahlqvist S.,Eriksson C.,Alm G.,Goring H. H.H.,Pastinen T.,Syvanen A.-C.,Ronnblom L.

Publisher

Oxford University Press (OUP)

Subject

Genetics (clinical),Genetics,Molecular Biology,General Medicine

Reference46 articles.

1. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

2. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

3. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

4. The type I interferon system in systemic lupus erythematosus

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants;npj Genomic Medicine;2024-07-16

2. Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients;Clinical Rheumatology;2024-07-04

3. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease;Frontiers in Immunology;2024-06-03

4. Hirsutella sinensis polysaccharides and Parabacteroides goldsteinii reduce lupus severity in imiquimod-treated mice;Biomedical Journal;2024-06

5. Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus;Clinical Immunology;2024-05